Decentralised manufacturing of cell and gene therapy products: learning from other healthcare sectors

Decentralised or 'redistributed' manufacturing represents an attractive choice for production of some cell and gene therapies (CGTs), in particular personalised therapies. Decentralised manufacturing splits production into various locations or regions and in doing so, imposes organisationa...

Full description

Saved in:
Bibliographic Details
Main Authors: Richard Harrison, Steven Ruck, Qasim A. Rafiq, Nick Medcalf
Format: Default Article
Published: 2017
Subjects:
Online Access:https://hdl.handle.net/2134/28186
Tags: Add Tag
No Tags, Be the first to tag this record!